Annual report pursuant to Section 13 and 15(d)

Net Loss per Share - Summary Of Potentially Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details)

v3.22.4
Net Loss per Share - Summary Of Potentially Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details) - shares
 12 Months Ended
Jan. 01, 2023
Jan. 02, 2022
Dec. 31, 2020
Stock options outstanding      
Subsidiary Sale Of Stock [Line Items]      
Anti-dilutive securities (in shares) 5,034,282 5,753,005 1,428,980
Restricted stock units and performance restricted stock units outstanding      
Subsidiary Sale Of Stock [Line Items]      
Anti-dilutive securities (in shares) 7,371,158 535,449 0
Private Placement Warrants outstanding      
Subsidiary Sale Of Stock [Line Items]      
Anti-dilutive securities (in shares) 0 6,000,000 0
Public Warrants outstanding      
Subsidiary Sale Of Stock [Line Items]      
Anti-dilutive securities (in shares) 0 4,322,106 0
Employee stock purchase plan estimated shares      
Subsidiary Sale Of Stock [Line Items]      
Anti-dilutive securities (in shares) 349,988 47,379 0